1. Home
  2. TCRX vs FUSE Comparison

TCRX vs FUSE Comparison

Compare TCRX & FUSE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo TScan Therapeutics Inc.

TCRX

TScan Therapeutics Inc.

SELL

Current Price

$0.14

Market Cap

11.8M

Sector

Health Care

ML Signal

SELL

Logo Fusemachines Inc.

FUSE

Fusemachines Inc.

HOLD

Current Price

$0.28

Market Cap

12.5M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
TCRX
FUSE
Founded
2018
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
EDP Services
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
11.8M
12.5M
IPO Year
2021
2025

Fundamental Metrics

Financial Performance
Metric
TCRX
FUSE
Price
$0.14
$0.28
Analyst Decision
Hold
Analyst Count
5
0
Target Price
★ $1.00
N/A
AVG Volume (30 Days)
★ 420.2K
61.9K
Earning Date
11-12-2026
11-03-2026
Dividend Yield
N/A
N/A
EPS Growth
12.28
★ 96.38
EPS
N/A
★ N/A
Revenue
★ $10,325,000.00
$7,714,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
★ 266.65
N/A
52 Week Low
$0.14
$0.22
52 Week High
$1.47
$3.67

Technical Indicators

Market Signals
Indicator
TCRX
FUSE
Relative Strength Index (RSI) 31.39 35.08
Support Level N/A $0.22
Resistance Level $0.21 $0.41
Average True Range (ATR) 0.02 0.05
MACD 0.00 0.00
Stochastic Oscillator 8.07 21.73

Price Performance

Historical Comparison
TCRX
FUSE

About TCRX TScan Therapeutics Inc.

TScan Therapeutics Inc is a fully integrated clinical-stage biotechnology company focused on developing a robust pipeline of T cell receptor (TCR)-engineered T cell, or TCR-T, therapies for the treatment of patients with cancer. The company's liquid tumor TCR-T therapy candidates, TSC-100 and TSC-101, are in development for the treatment of patients with hematologic malignancies to eliminate residual leukemia and prevent relapse after hematopoietic stem cell transplantation. It is also developing multiplexed TCR-T therapy candidates for the treatment of various solid tumors.

About FUSE Fusemachines Inc.

Fusemachines Inc is a provider of enterprise AI solutions, offering products such as AI Studio, AI Engines, and AI Agents, along with supporting services across various industries. Its solutions are supported by a talent pool from underserved communities, enabling scalable and high-quality AI delivery while promoting access to AI. The Company serves clients across industries, including healthcare, media, technology, and government, helping address challenges such as improving forecasting accuracy, reducing data entry errors, automating recruitment, and detecting fraud. Its product suite includes AI Studio, AI Engines, and AI Agents, designed to build, deploy, and scale AI solutions, and it operates in Nepal and the United States.

Share on Social Networks: